Chinese biotech's out-licensing boom hits a wall as drug giants tighten budgets
Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.

Loading the Newsroom
Curating from trusted global sources…
84 briefings · “ice”
Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.
A developer found that Microsoft's Paint and Photos embed a unique ID tied to your prompts, raising privacy questions for businesses and creators.
The winding-down RSN operator claims cable giants shortchanged regional sports networks, a fight with billions in implications.
A new daily sea-surface temperature record signals accelerating climate risk for coastal economies, insurers, and supply chains.
The fast-fashion giant's long-awaited listing lands at a steep discount to its private-market heyday, resetting expectations for investors and rivals.
Universal’s R-rated, near-three-hour action-adventure scores $264.1M worldwide, including $139.6M international and $124.5M domestic.
The deal doubles Uber's dual-services footprint and pushes a ride-and-eats bundling play into 50 more markets.
Two voice models, GPT-Live-1 and GPT-Live-1 mini, let ChatGPT listen and speak at once, plus stream longer reasoning.
The tax-free spin-off could reshape focus, funding, and competition across media and tech for years.
CNBC says SpaceX’s shares surge following its IPO Friday, forcing investors to reprice what “space” and “AI” are worth.
The Aussie mining billionaire just put Hancock Prospecting behind Musk's rocket-and-satellite combo, and markets noticed.
A 20% first-day pop pushes Musk past a 13-digit milestone and forces markets to reprice space risk.